Simtra US LLC

Bloomington, United StatesFEI 1000115571

Simtra US LLC is a drug establishment in Bloomington, United States, registered with the US FDA under FEI 1000115571. Its registered operations are: Analytical testing, Labelling, Drug manufacture, Packaging, Relabelling, Sterilisation. 1 EU/UK GMP certificate is matched to this site, 1 inspected within the last three years. FDA has published 12 inspection outcomes for this FEI; the most recent, ended 24 Sept 2024, was classified voluntary action indicated (VAI).

Sources: FDA Drug Establishments Current Registration Site (checked 16 Nov 2026); FDA Data Dashboard (inspections); EudraGMDP; MHRA GMDP. Methodology

Cite as: PharmaTek, “Simtra US LLC: FDA registration, inspection and GMP record (FEI 1000115571)”, record as of 16 Nov 2026, pharmatek.co.uk/manufacturing-sites/simtra-us-llc-bloomington-1000115571

Registered operations

Business operations this establishment declares in its FDA registration. Registration is not an approval and says nothing about EU or UK GMP status.

Analytical testingLabellingDrug manufacturePackagingRelabellingSterilisation

GMP documents matched to this site (1)

DocumentAuthorityInspectionSource
NL/H 26/2059734
GMP certificate
Competent authority of Netherlands14 Aug 2026
within 3-year review window
EudraGMDP

A GMP document is matched to this site when its address names the site's street and its city or postcode. In our latest internal review 59 of 60 sampled matches were the right site (not yet independently reviewed; measured match quality). Check the certificate's own address before relying on it. The three-year review window is the EMA guideline default after an inspection, not an official expiry date.

FDA inspection outcomes (12)

Inspection endedOutcomeProgramme areaCitations posted
24 Sept 2024VAI · Voluntary action indicatedDrug Quality AssuranceNo
17 Feb 2023NAI · No action indicatedDrug Quality AssuranceNo
17 Jul 2017VAI · Voluntary action indicatedDrug Quality AssuranceYes
24 Oct 2014VAI · Voluntary action indicatedDrug Quality AssuranceNo
2 May 2014NAI · No action indicatedDrug Quality AssuranceNo
10 May 2013VAI · Voluntary action indicatedDrug Quality AssuranceYes
12 Mar 2013VAI · Voluntary action indicatedDrug Quality AssuranceYes
27 Sept 2012VAI · Voluntary action indicatedDrug Quality AssuranceNo
16 Aug 2011NAI · No action indicatedDrug Quality AssuranceNo
25 Mar 2011VAI · Voluntary action indicatedDrug Quality AssuranceYes
23 Sept 2010VAI · Voluntary action indicatedDrug Quality AssuranceNo
30 Oct 2009NAI · No action indicatedDrug Quality AssuranceNo

FDA Data Dashboard, joined on the FEI. NAI: no objectionable conditions found. VAI: objectionable conditions found, but not serious enough for regulatory action. OAI: regulatory or administrative action recommended. A classification describes one inspection on one date; FDA publishes it only once final and does not publish every inspection. FDA firm profile

Form 483 observations (9)

Inspection ended 17 Jul 2017: 1 observation
  • 21 CFR 211.113(b) Validation lacking for sterile drug products
Inspection ended 10 May 2013: 4 observations
  • 21 CFR 211.22(d) Procedures not in writing, fully followed
  • 21 CFR 211.80(a) Procedures To Be in Writing
  • 21 CFR 211.100(b) SOPs not followed / documented
  • 21 CFR 211.84(d)(3) Certificates of Testing (Containers, Closures)
Inspection ended 12 Mar 2013: 2 observations
  • 21 CFR 211.113(b) Procedures for sterile drug products
  • 21 CFR 211.192 Extent of discrepancy, failure investigations
Inspection ended 25 Mar 2011: 2 observations
  • 21 CFR 211.192 Extent of discrepancy, failure investigations
  • 21 CFR 211.22(d) Procedures not in writing, fully followed

FDA Data Dashboard (inspection citations), joined on the FEI. Each line is the regulation cited and FDA's short description, not the full observation text. A Form 483 lists an investigator's observations at the close of an inspection; it is not a final agency determination, and FDA does not publish citations for every inspection.

What this page does not show

  • Which substances are made here: DMFs and CEPs are filed by organisations, not sites, so we do not link substances to this site.
  • Capacity, scale, price or current availability: no regulator publishes these.
  • The full text of a Form 483 or warning letter: FDA's dashboard gives the regulation cited and a short description only.

Other sites registered by the same company

For suppliers

Is this SIMTRA US LLC?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.